MTaI welcomes government's budget focus on MedTech and healthcare
MTaI welcomed Budget 2019 health measures, backing AI in healthcare, new AIIMS, and govt’s mission-mode push for the medical devices sector.
Read More
Exclusive Vertical in CDSCO will check & Garage Manufacturing: MTaI
MTaI welcomes a dedicated CDSCO medical devices vertical to curb unregulated “garage manufacturing” and strengthen patient safety through better regulation.
Read More
Customs duty cut: First of many budget corrections needed in medtech
High customs duties and blunt price controls raise device costs, undercutting PMJAY’s affordability goals despite strong early uptake of the scheme.
Read More
Union Budget 2019 -High custom duties adversely impact the medical devices in India : Pavan Choudary, Chairman and DG MTaI
The custom duty regime on most medical devices in neighboring countries such as Nepal, Bangladesh, Sri-Lanka, and Bhutan is lower than in India.
Read More
MTaI Seeks Streamlining Of Taxes And Duties To Make Medical Devices Affordable
Medical Technology Association of India (MTaI), today said the government should streamline tax and duty structure in Union Budget 2019-20 to ensure people get long-term access to quality medical devices.
Read More
Acceptance of eIFU for Medical Device a Welcome Move: MTaI
Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant investments in India, today welcomed the Ministry of Health & Family Welfare Gazette notification on acceptance
Read More
Inclusion of medical device industry in DTAB panel on compensation a step in right direction, says MTaI
MTaI welcomed the DTAB sub-committee to examine compensation norms under MDR 2017, calling industry inclusion a positive step toward a balanced.
Read More
Overview of 2018 for med-tech and expectations for 2019
India’s MedTech sector is a sunrise industry, expected to grow from $6.3 bn to $9.5 bn in four years: Pavan Choudary.
Read More
Increase in stent prices shows govt’s commitment to quality healthcare: MTaI
MTaI says NPPA’s 4.2% stent price hike aligns with inflation, supports industry viability, and signals govt’s commitment to quality healthcare.
Read More